Possibility of active targeting to tumor tissues with liposomes
- 1 November 1999
- journal article
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 40 (1-2), 89-102
- https://doi.org/10.1016/s0169-409x(99)00042-3
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Health and Welfare
- Ministry of Education, Culture, Sports, Science and Technology (9-Specified)
This publication has 27 references indexed in Scilit:
- Targetability of novel immunoliposomes modified with amphipathic poly(ethylene glycol) s conjugated at their distal terminals to monoclonal antibodiesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1995
- Improvement of Therapeutic Effect by Using Fab' Fragment in the Treatment of Carcinoembryonic Antigen‐positive Human Solid Tumors with Adriamycinentrapped ImmunoliposomesJapanese Journal of Cancer Research, 1994
- Targeted delivery of biologic and other antineoplastic agentsCurrent Opinion in Oncology, 1992
- Prolonged circulation time in vivo of large unilamellar liposomes composed of distearoyl phosphatidylcholine and cholesterol containing amphipathic poly(ethylene glycol)Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
- The tumor blood vessel as an ideal target for macromolecular anticancer agentsJournal of Controlled Release, 1992
- Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomesFEBS Letters, 1990
- Uptake and processing of immunoglobulin-coated liposomes by subpopulations of rat liver macrophagesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 1988
- Large unilamellar liposomes with low uptake into the reticuloendothelial systemFEBS Letters, 1987
- Extravascular transport in normal and tumor tissuesCritical Reviews in Oncology/Hematology, 1986
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975